FDA approves Emflaza to treat Duchenne muscular dystrophy

What is Emflaza? Emflaza (Deflazacort) is a glucocorticoid, a class of corticosteroids used as an anti-inflammatory and immunosuppressant. Deflazacort works by decreasing inflammation and reducing the activity of the immune system to treat certain conditions such as: acute interstitial nephritis, anaphylaxis, asthma, anemia, Crohn’s disease, dermatomyositis, idiopathic thrombocytopenic purpura, juvenile chronic arthritis, acute and lymphatic […]

Read Full Article